Click on a therapy to read the latest news:

While there are currently several FDA approved therapies on the market for treating patients with Relapsing Multiple Sclerosis, there are currently none that specifically target the progressive forms of the disease. However, there are many experimental progressive MS therapies currently in the research and development pipeline, with some showing real promise for being approved.

Subscribe to Multiple Sclerosis News Today‘s tri-weekly e-newsletter and get the latest updates about experimental Multiple Sclerosis therapies.

Subscribe to our mailing list

* indicates required

List compiled from data taken from the MS Trust, Multiple Sclerosis Discovery Forum, and drug developer websites. While Multiple Sclerosis News Today makes a best effort to keep pipeline information accurate and up-to-date, this information is not guaranteed and is only meant as an information resource. Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.